Somaxon Pharmaceuticals, Inc (NASDAQ:SOMX) Somaxon Pharmaceuticals, Inc. (Somaxon) is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of branded products and late-stage product candidates. Somaxon Pharmaceuticals, Inc witnessed volume of 1.33 million shares during last trade however it holds an average trading capacity of 162,749 shares.

TISI, Team Inc.

** On its first quarter of fiscal 2012, TISI posted revenues of $141.1 million, a 35% increase year over year and net income of $6.8 million, up 78% from the same quarter last year.

PTS, Inc. (OTC.BB:PTSH) announced that through its ThinLine division it has signed a 3 year IT Services deal with United Power.